Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

HIV Antibody Tests Unreliable For Early Infections In Teens
A previously healthy teenager shows up at the doctor"s office with a sore throat, fever, aches and general malaise. Routine blood tests are normal, an HIV test comes back negative, and the pediatrician sends the patient home with a diagnosis of acute viral infection.

AVI BioPharma, Inc. To Present At 7th Annual Biodefense Vaccines & Therapeutics Conference In Washington, D.C.
AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, announced that Patrick Iversen, Ph.D., Senior Vice President of Strategic Alliances, will present at the upcoming 7th Annual Biodefense Vaccines & Therapeutics conference taking place in Washington, D.C.
News of the day
Abnormal Brain Circuits May Prevent Movement Disorder
Most people who carry a genetic mutation for a movement disorder called dystonia will never develop symptoms, a phenomenon that has puzzled scientists since the first genetic mutation was identified in the 1990"s. Now, scientists at The Feinstein Institute for Medical Research have figured out why these mutation carriers are protected from symptoms of the disorder they have an additional lesion that evens the score.
Endocrinology

FDA Approve One-Pill Version Of Plan B, Sets Over-The-Counter Access At Age 17

FDA approved Teva Pharmaceuticals" Plan B One-Step -- a single-pill version of the two-pill dose emergency contraceptive product Plan B -- and lowered the limit for over-the-counter purchase of the drug to age 17, the company announced on Monday, the AP/Yahoo! Finance reports (AP/Yahoo! Finance, 7/13). Individuals ages 16 and younger will be required to obtain prescriptions to purchase Plan B, which reduces the chance of pregnancy when taken within 72 hours of sexual intercourse (Teva Pharmaceuticals release, 7/13). Teva said the one-pill version will be available at retail pharmacies in August (AP/Yahoo! Finance, 7/13). Kelli Conlin, president of the National Institute for Reproductive Health, said, "Health care providers and women"s advocates have been eager for a one-pill emergency contraceptive for years and are happy to see it finally come to fruition" (Teva Pharmaceuticals release, 7/13).The expanded access to the medication comes several months after a federal court lifted restrictions put in place under former President George W. Bush that limited OTC sales to women ages 18 and older (AP/Yahoo! Finance, 7/13). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009